Package 70954-413-40

{"route": ["ORAL"], "spl_id": "394da62e-fb31-4d2b-9ca3-3f6dc2d04013", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "upc": ["0370954413301", "0370954412304", "0370954414100", "0370954412106"], "unii": ["0J48LPH2TH", "UR59KN573L"], "rxcui": ["854908", "854916", "854919"], "spl_set_id": ["a26bcf78-6515-4e9f-b2dc-4aaa8ec1a82c"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["ANI Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (70954-413-10)", "package_ndc": "70954-413-10", "marketing_start_date": "20211104"}, {"sample": false, "description": "100 TABLET in 1 BOTTLE (70954-413-30)", "package_ndc": "70954-413-30", "marketing_start_date": "20211104"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (70954-413-40)", "package_ndc": "70954-413-40", "marketing_start_date": "20211104"}], "brand_name": "Bisoprolol Fumarate and Hydrochlorothiazide", "product_id": "70954-413_394da62e-fb31-4d2b-9ca3-3f6dc2d04013", "dosage_form": "TABLET", "pharm_class": ["Adrenergic beta-Antagonists [MoA]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]", "beta-Adrenergic Blocker [EPC]"], "product_ndc": "70954-413", "generic_name": "Bisoprolol Fumarate and Hydrochlorothiazide", "labeler_name": "ANI Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bisoprolol Fumarate and Hydrochlorothiazide", "active_ingredients": [{"name": "BISOPROLOL FUMARATE", "strength": "5 mg/1"}, {"name": "HYDROCHLOROTHIAZIDE", "strength": "6.25 mg/1"}], "application_number": "ANDA215562", "marketing_category": "ANDA", "marketing_start_date": "20211104", "listing_expiration_date": "20261231"}